Literature DB >> 89064

HLA and cell-mediated immunity in HBsAg negative chronic active hepatitis.

A J Vogten, R G Shorter, G Opelz.   

Abstract

In 20 patients with severe HBsAg negative chronic active hepatitis a significant association has been found between the HLA determinants A1, B8, and Dw3 and cell-mediated immunity directed against human liver specific lipoprotein in vitro. This observation induces further speculation that genetic immunoregulatory action might be involved in the pathogenetic mechanisms of chronic active hepatitis in vivo.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 89064      PMCID： PMC1412459          DOI： 10.1136/gut.20.6.523

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


  15 in total

1.  Association of autoimmune active chronic hepatitis with HL-A1,8.

Authors:  I R Mackay; P J Morris
Journal:  Lancet       Date:  1972-10-14       Impact factor: 79.321

2.  Failure of customary treatment in chronic active liver disease: causes and management.

Authors:  S W Schalm; H V Ammon; W H Summerskill
Journal:  Ann Clin Res       Date:  1976-06

Review 3.  The major histocompatibility complex--genetics and biology (second of three parts).

Authors:  F H Bach; J J Rood
Journal:  N Engl J Med       Date:  1976-10-14       Impact factor: 91.245

Review 4.  The major histocompatibility complex--genetics and biology. (First of three parts).

Authors:  F H Bach; J J van Rood
Journal:  N Engl J Med       Date:  1976-10-07       Impact factor: 91.245

5.  HLA determinants in chronic active liver disease: possible relation of HLA-Dw3 to prognosis.

Authors:  G Opelz; A J Vogten; W H Summerskill; S W Schalm; P I Terasaki
Journal:  Tissue Antigens       Date:  1977-01

6.  Antibody-dependent cell-mediated (K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis.

Authors:  A M Cochrane; A Moussouros; A D Thomsom; A L Eddleston; R Wiiliams
Journal:  Lancet       Date:  1976-02-28       Impact factor: 79.321

7.  Genetic analysis of patients with chronic active hepatitis.

Authors:  A R Page; H L Sharp; L J Greenberg; E J Yunis
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

8.  Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

Authors:  A P Geubel; R H Keller; W H Summerskill; E R Dickson; T B Tomasi; R G Shorter
Journal:  Gastroenterology       Date:  1976-09       Impact factor: 22.682

9.  Lymphocyte cytotoxicity in chronic active hepatitis: effect of therapy and correlations with clinical and histological changes.

Authors:  A M Cochrane; A Moussouros; A Smith; B Portmann; A L Eddleston; R Williams
Journal:  Gut       Date:  1978-04       Impact factor: 23.059

10.  Cell-mediated cytotoxicity in chronic active liver disease: a new test system.

Authors:  A J Vogten; N Hadzic; R G Shorter; W H Summerskill; W F Taylor
Journal:  Gastroenterology       Date:  1978-05       Impact factor: 22.682
View more
  2 in total

1.  HLA-B8 and cell-mediated immunity to gluten.

Authors:  F G Simpson; A W Bullen; D A Robertson; M S Losowsky
Journal:  Gut       Date:  1981-08       Impact factor: 23.059

Review 2.  Genetic determinants of autoimmune chronic active hepatitis.

Authors:  I R Mackay; S Whittingham; J D Mathews; B D Tait
Journal:  Springer Semin Immunopathol       Date:  1980-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.